<unk>  is common in people with type 1 diabetes, especially in those taking insulin, glinides, or sulfonylurea. It is estimated that type 1 diabetics experience two mild, symptomatic episodes of<unk>  per week. Additionally, type 1 diabetics suffer from at one severe hypoglyemic episode per year, requiring treatment assistance. In terms of mortality,<unk>  causes death in 6-10% of type 1 diabetics. In those with type 2 diabetes,<unk>  is less common compared to type 1 diabetics, because medications that treat type 2 diabetes like metformin, glitazones, alpha-glucosidase inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase IV inhibitors, do not cause<unk> .<unk>  is common in type 2 diabetics who take insulin, glinides, or sulfonylurea. Insulin use remains a key risk factor in developing<unk> , regardless of diabetes type.
Hypoglycemia
Stroke
Oxyhyperglycemia
Hepatic encephalopathy
Ketotic hypoglycemia
Drowning
Hyperinsulinemic hypoglycemia
Opioid overdose